Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers May 30, 2017
Pharmacy Choice - News - Front Page Healthcare News - May 30, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

5/29/17 - "Nano- and Micro-Sized Particles of 20-Camptothecin Or Derivative Thereof and Pharmaceutical Compositions Containing Same, and Treatment of Cancers...
"Nano- and Micro-Sized Particles of 20- Camptothecin Or Derivative Thereof and Pharmaceutical Compositions Containing Same, and Treatment of Cancers Therewith" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Cancer Gene Therapy Week A patent application by the inventors CHEN, Wenhao; ZHANG, Jiyao; CAO, Zhisong, fil
5/29/17 - "Oral Administration of Melanin for Protection against Radiation" in Patent Application Approval Process (USPTO 20170128416)
By a News Reporter-Staff News Editor at Bioterrorism Week A patent application by the inventors Dadachova, Ekaterina; Casadevall, Arturo, filed on August 8, 2016, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Albert Einstei
5/29/17 - "Rapidly Disintegrating Films for Delivery of Pharmaceutical Or Cosmetic Agents" in Patent Application Approval Process (USPTO 20170128358)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors BARNHART, Scott D.; FULL, Andrew P.; MORITZ, Cathy M., filed on January 24, 2017, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not bee
5/29/17 - "Stable Pharmaceutical Composition and Methods of Using Same" in Patent Application Approval Process (USPTO 20170128402)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Manku, Mehar; Osterloh, Ian; Wicker, Pierre; Braeckman, Rene; Soni, Paresh, filed on January 25, 2017, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent ap
5/29/17 - "Sustained Release Pharmaceutical Compositions and Methods of Use" in Patent Application Approval Process (USPTO 20170128424)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor ROTHSTEIN, Sam, filed on November 11, 2016, was made available online on May 18, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution.
5/29/17 - Aileron Therapeutics Announces Oral Presentation at ASCO on ALRN-6924 Targeting p53
By a News Reporter-Staff News Editor at Clinical Trials Week Aileron Therapeutics, a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, announced that the Company's abstract for ALRN-6924, its lead stapled peptide product candidate targeting p53, was selected for an oral presentation at the 2
5/29/17 - Amaranth Medical Provides Clinical and Commercial Update on 115-micron APTITUDE Sirolimus-Eluting Bioresorbable Scaffold
By a News Reporter-Staff News Editor at Clinical Trials Week Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, presented nine-month follow-up results from the company's RENASCENT-II study of the APTITUDE sirolimus-eluting bioresorbable scaffold on Tuesday,...
5/29/17 - Amerigroup Georgia Receives Multicultural Health Care Distinction from the National Committee for Quality Assurance
By a News Reporter-Staff News Editor at Managed Care Weekly Digest Amerigroup Community Care of Georgia, a leading statewide provider of Medicaid managed care services, announced that is has been recognized by the National Committee for Quality Assurance, which awards distinction to organizations that meet or exceed its rigorous requirements for.
5/29/17 - Amgen Submits Biologics License Application To The FDA For Erenumab
By a News Reporter-Staff News Editor at Biotech Business Week Amgen announced the submission of a Biologics License Application to the U.S. Food and Drug Administration for erenumab to prevent migraine. Approximately 3.5 million Americans currently take a preventive treatment to reduce their number of migraine days, yet 80 percent of those discon
5/29/17 - AmpliPhi Biosciences Reports First Quarter 2017 Financial Results and Provides Business Highlights
By a News Reporter-Staff News Editor at Clinical Trials Week AmpliPhi Biosciences Corporation, a leader in the development of therapies for antibiotic-resistant infections using bacteriophage technology, announces financial results for the quarter ended March 31, 2017 and provides business highlights. "We are enthusiastic about our new strategic
5/29/17 - Aptar Pharma's Electronic Lockout Device Approved by EMA
By a News Reporter-Staff News Editor at Pharma Business Week Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the European Medicines Agency of the first integrated electronic nasal lockout device following a multi-year development with Takeda Pharmaceuticals International AG.
5/29/17 - Aries Pharmaceuticals, Inc. Shares Positive Results for Clinical Study of Eleview? at Digestive Disease Week Annual Meeting
By a News Reporter-Staff News Editor at Clinical Trials Week Aries Pharmaceuticals, Inc., a specialty pharmaceutical company commercializing best-in-class gastroenterology products, shared positive results of the first Eleview? clinical trial in humans at the annual Digestive Disease Week conference in Chicago, Illinois earlier this month.
5/29/17 - ArQule to Present Clinical Data at the 2017 American Society of Clinical Oncology ASCO Annual Meeting
By a News Reporter-Staff News Editor at Clinical Trials Week ArQule, Inc. announced that data from the phase 1/ 2 trial in intrahepatic cholangiocarcinoma with fibroblast growth factor receptor inhibitor, ARQ 087, will be presented on June 3, 2017 at the 2017 ASCO Annual Meeting in Chicago, Illinois. The company has been granted orphan drug desig
5/29/17 - Astellas Announces Oncology Portfolio Updates
By a News Reporter-Staff News Editor at Clinical Trials Week Astellas Pharma Inc. announced an update regarding the Company's diverse oncology portfolio, including the acceptance of a wide selection of abstracts across a broad range of cancers for oral or poster presentation at the 2017 American Society of Clinical Oncology Annual Meeting, June 2
5/29/17 - Aurinia Reports First Quarter 2017 Financial Results, Announces Initiation of Phase III Aurora Clinical Trial, and Provides Operational Highlights
By a News Reporter-Staff News Editor at Clinical Trials Week Aurinia Pharmaceuticals Inc. has released its financial results for the first quarter ended March 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars. Recent operational highlights 48- Week AURA-LV Data presented in Late Breaker Presentation at National Kidney..
5/29/17 - Bayer to Highlight Oncology Franchise Research at ASCO 2017
By a News Reporter-Staff News Editor at Clinical Trials Week Bayer announced that the latest research from across its growing oncology portfolio will be presented at the 53rd Annual Meeting of the American Society of Clinical Oncology, taking place June 2-6 in Chicago. Earlier today, the U.S. Food and Drug Administration granted Priority Review d
5/29/17 - Biogen Acquires Remedy Pharmaceuticals' CIRARA? for Large Hemispheric Stroke
By a News Reporter-Staff News Editor at Pharma Business Week Biogen announced that it has completed an asset purchase of Remedy Pharmaceuticals' Phase 3 candidate, CIRARA?. The U.S. Food and Drug Administration recently granted CIRARA Orphan Drug Designation for severe cerebral edema in patients with acute ischemic stroke. Each year approximate
5/29/17 - Biogen Acquires Remedy Pharmaceuticals' Late-Stage Drug CIRARA?
By a News Reporter-Staff News Editor at Pain& Central Nervous System Week Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving treatments to people affected by central nervous system diseases and injuries, announced that Biogen completed an asset purchase of its Phase 3 candidate, CIRARA.
5/29/17 - Biohaven's Trigriluzole Receives Fast Track Designation From U.S. FDA
By a News Reporter-Staff News Editor at Clinical Trials Week Biohaven Pharmaceutical Holding Company Ltd. announced that the U.S. Food and Drug Administration has granted the company Fast Track Designation for Biohaven's product candidate trigriluzole for the potential treatment of Spinocerebellar Ataxia. Trigriluzole previously received Orphan
5/29/17 - Blood Pressure Monitoring Devices & Accessories Market - Hospitals, Ambulatory Surgical Centers, Clinics, and Homecare Settings - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
This report on the global blood pressure monitoring devices& accessories market analyzes the current and future scenario of the global market. Rise in private and public funding for diagnostic medical devices, rising demand for advanced blood pressure monitoring devices, and favorable regulatory scenario for new device launch are boosting the gro
5/29/17 - Can-Fite Files Clinical Trial Application in Canada for Piclidenoson Ahead of Upcoming Acrobat Rheumatoid Arthritis Phase III Study
By a News Reporter-Staff News Editor at Clinical Trials Week Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it has filed a Clinical Trial Application with Health Canada for Piclidenoson. Having recently received Institutional
5/29/17 - Chi-Med Presents Clinical Data at ASCO 2017 Annual Meeting
By a News Reporter-Staff News Editor at Clinical Trials Week Hutchison China MediTech Limited announces that new clinical data on three of its novel tyrosine kinase inhibitors, fruquintinib, savolitinib and sulfatinib, will be presented at the 2017 American Society of Clinical Oncology Annual Meeting, to be held in Chicago, Illinois from June 2 t
5/29/17 - Cleveland Clinic Abu Dhabi completes successful kidney transplant [Emirates News Agency (WAM) (United Arab Emirates)]
ABU DHABI, 29th May, 2017 Physicians at Cleveland Clinic Abu Dhabi successfully completed a kidney transplant operation in May, taking the hospital another step towards providing full transplant facilities in-line with the recent changes in UAE legislation. The patient, Moza Salem Almansouri, a 73- year-old UAE national who suffers from both diab
5/29/17 - Cleveland HeartLab: Is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests.
Cleveland HeartLab, Inc. is a specialty clinical laboratory and disease management company focused on novel biomarker technologies and the creation of proprietary diagnostic tests. President& CEO at Cleveland HeartLab. Director of Finance and Administration at Cleveland HeartLab.
5/29/17 - Clinical Trial Management System Market has been evaluated as a growing market, expected to grow with CAGR of 15% by 2022
Global Clinical trial management system Market Information, By Type, By Application, By End Users- Forecast Till 2022. Market research future published a half-cooked research report on global clinical trial management system market. The global clinical trial management system market is expected to grow at a CAGR of 15% during the period 2016 to 202
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Telepharmacy- Remote Delivery of Pharmacy Services
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415